Cargando…
Potentials and limitations of adenovirus-p53 gene therapy for brain tumors.
We investigated the antineoplastic potentials of recombinant adenovirus containing wild-type p53 cDNA (Ad5CMV-p53) for malignant gliomas. In four human glioma cell lines (U-251 and LG expressing endogenous mutant p53, and U-87 and EFC-2 expressing wild-type p53) and two rat glioma cell lines (9L and...
Autores principales: | Hong, Y. K., Joe, Y. A., Yang, Y. J., Lee, K. S., Son, B. C., Jeun, S. S., Chung, D. S., Cho, K. K., Park, C. K., Kim, M. C., Kim, H. K., Yung, W. K., Kang, J. K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054646/ https://www.ncbi.nlm.nih.gov/pubmed/10895975 |
Ejemplares similares
-
Silencing E1A mRNA by RNA interference inhibits adenovirus replication
por: Chung, Y.-S., et al.
Publicado: (2007) -
p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
por: Yoon, K. S., et al.
Publicado: (2001) -
The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer.
por: Kang, Y. H., et al.
Publicado: (2001) -
Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas.
por: Cho, H., et al.
Publicado: (1999) -
Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
por: Lee, S. H., et al.
Publicado: (1995)